New Releases from NCBI BookshelfEvolocumab (Repatha): Therapeutic area: Primary hyperlipidemia: Reimbursement Review [Internet].Evolocumab (Repatha): Therapeutic area: Primary hyperlipidemia: Reimbursement Review [Internet].By admin / January 27, 2025 Post Content
